Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

476
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
476
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

260
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
260
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

368
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
368
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

399
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
399
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

498
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
498
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

449
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
449

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Expert consensus on case definitions in human loiasis: a Delphi study.

The Lancet. Infectious diseases·2026
Same author

A novel JAK1 variant in chronic eosinophilic leukaemia with response to benralizumab.

British journal of haematology·2026
Same author

Circulating eosinophils in patients with hypereosinophilic syndrome have heterogeneous immunophenotypes.

The journal of allergy and clinical immunology. Global·2026
Same author

Author Correction: Benralizumab versus placebo for hypereosinophilic syndrome: a randomized, placebo-controlled phase 3 trial.

Nature medicine·2026
Same author

Benralizumab versus placebo for hypereosinophilic syndrome: a randomized, placebo-controlled phase 3 trial.

Nature medicine·2026
Same author

Differential Diagnosis of Eosinophilic Lung Diseases.

The journal of allergy and clinical immunology. In practice·2026
Same journal

Seeds, Spices-Not Always so Nice: A Report on the FARE (Food Allergy Research & Education) Patient Registry.

The journal of allergy and clinical immunology. In practice·2026
Same journal

Combined large and small airway obstruction is associated with increased exacerbation frequency and poorer symptom control in persistent asthma.

The journal of allergy and clinical immunology. In practice·2026
Same journal

Reply to "Omalizumab in venom immunotherapy: can we improve tolerance even further?"

The journal of allergy and clinical immunology. In practice·2026
Same journal

Omalizumab in venom immunotherapy: Can we improve tolerance even further?

The journal of allergy and clinical immunology. In practice·2026
Same journal

Reply to "Omalizumab-assisted venom immunotherapy: The need for standardized qualification and protocol-dependent risk assessment".

The journal of allergy and clinical immunology. In practice·2026
Same journal

Omalizumab-assisted venom immunotherapy: The need for standardized qualification and protocol-dependent risk assessment.

The journal of allergy and clinical immunology. In practice·2026
查看所有相关文章

相关实验视频

Updated: Jan 14, 2026

Author Spotlight: Investigating the Pathophysiology of Eosinophilic Esophagitis
03:23

Author Spotlight: Investigating the Pathophysiology of Eosinophilic Esophagitis

Published on: May 10, 2024

1.3K

异性心脏干扰 异性心脏干扰

Jessica Bass1, Amy D Klion1

  • 1Human Eosinophil Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md.

The journal of allergy and clinical immunology. In practice
|October 17, 2025
PubMed
概括
此摘要是机器生成的。

过敏氨基酸,一种具有高氨基酸细胞数量的疾病,可以影响心脏. 这项研究概述了两名患者的诊断和治疗策略,这些患者由于过敏氨酸友爱症出现了类似的心脏干扰.

关键词:
内心肌纤维化是内心肌纤维化的一种.埃索诺菲利亚是什么意思乙性白血病 (Eosinophilic Leukemia) 是一种类型的白血病.罗亚罗亚罗亚 罗亚罗亚寄生虫感染是一种寄生虫感染.

更多相关视频

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling
08:25

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling

Published on: April 7, 2015

9.5K
Isolation and Identification of Extravascular Immune Cells of the Heart
08:24

Isolation and Identification of Extravascular Immune Cells of the Heart

Published on: August 23, 2018

13.9K

相关实验视频

Last Updated: Jan 14, 2026

Author Spotlight: Investigating the Pathophysiology of Eosinophilic Esophagitis
03:23

Author Spotlight: Investigating the Pathophysiology of Eosinophilic Esophagitis

Published on: May 10, 2024

1.3K
Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling
08:25

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling

Published on: April 7, 2015

9.5K
Isolation and Identification of Extravascular Immune Cells of the Heart
08:24

Isolation and Identification of Extravascular Immune Cells of the Heart

Published on: August 23, 2018

13.9K

科学领域:

  • 心脏病学 心脏病学
  • 血液学 血液学 血液学
  • 内部医学 内部医学

背景情况:

  • 过高氨基酸含量症的特征是以高氨基酸水平为特征.
  • 心脏干扰是高氨酸的严重并发症.
  • 不同的潜在原因可能导致过敏氨酸性.

研究的目的:

  • 描述诊断和治疗方法.
  • 介绍两个心脏过敏氨基的临床病例.
  • 为了突出临床表现的相似之处.

主要方法:

  • 案例报告分析.案例报告分析.
  • 对高氨酸友爱症的诊断工作的审查.
  • 对心脏干扰的治疗方式的评估.

主要成果:

  • 确定了两个具有类似心脏过敏氨基的临床表现的病例.
  • 诊断挑战和发现是详细的.
  • 讨论了治疗策略和结果.

结论:

  • 及时诊断和量身定制的治疗对于治疗心脏过敏氨酸是至关重要的.
  • 了解各种原因对于有效管理至关重要.
  • 类似的介绍强调了需要采用系统的方法.